2940-20-7 Usage
Uses
Used in Pharmaceutical Industry:
Ethanone, 1-[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]is used as an anti-inflammatory agent for the treatment of various inflammatory conditions such as arthritis, menstrual cramps, and ankylosing spondylitis. It is effective in reducing pain, inflammation, and swelling associated with these conditions, thereby improving the quality of life for patients.
Ethanone, 1-[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]is used as a pain reliever for the management of mild to moderate pain caused by various conditions. Its ability to block the production of inflammatory substances in the body makes it a suitable option for pain relief.
Ethanone, 1-[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]is used as an oral medication, commonly available in capsule form, for the convenience of patients. It can be easily administered and absorbed by the body, ensuring effective treatment of inflammatory conditions.
Ethanone, 1-[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]is used under the prescription of healthcare professionals, ensuring that patients receive the appropriate dosage and treatment plan for their specific condition. This helps in optimizing the therapeutic outcomes and minimizing potential side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 2940-20-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,9,4 and 0 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2940-20:
(6*2)+(5*9)+(4*4)+(3*0)+(2*2)+(1*0)=77
77 % 10 = 7
So 2940-20-7 is a valid CAS Registry Number.
2940-20-7Relevant academic research and scientific papers
Practical Deoxygenation of Oxazole N-Oxides by PCl 3/Collidine
Shirinian, Valerii Z.,Lonshakov, Ilya A.,Zakharov, Alexey V.,Lvov, Andrey G.,Krayushkin, Mikhail M.
, p. 414 - 420 (2019/01/10)
A new chemoselective method for the synthesis of 2-aryl-1,3-oxazoles by deoxygenation of the corresponding N-oxides has been developed. As the deoxygenation reagent, a previously unknown complex of collidine with phosphorus trichloride in a 2:1 ratio has
PROTEOSTASIS REGULATORS
-
Page/Page column 44-45, (2013/02/27)
The present invention is directed to compounds having the Formulae (Ia-Ie), (II), (IIIa-IIId), (IVa-IVc), (Va-Vb), (VIa-VIe), (VII), (VIIIa-VIIIc), and (IX), pharmaceutically acceptable salts, prodrugs and solvates thereof, compositions of any of thereof and methods for the treatment of a condition associated with a dysfunction in proteostasis comprising an effective amount of these compounds.
